NDC 51672-4045-01 - Enalapril Maleate and Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-4045
- Requested NDC
- 51672-4045-01
- Package NDCs from labels
- 51672-4045-1, 51672-4045-3, 51672-4045-01
- Manufacturer
- Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries, Ltd.
- Effective date
- 2026-07-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Enalapril Maleate and Hydrochlorothiazide Tablets, USP | Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries, Ltd. | 2026-07-14 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-4045-1 | Enalapril Maleate and Hydrochlorothiazide | 100 in 1 BOTTLE | TABLET | 100 | 12 | |
| 51672-4045-3 | Enalapril Maleate and Hydrochlorothiazide | 1000 in 1 BOTTLE | TABLET | 1000 | 12 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-4045 | ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE TABLET [TARO PHARMACEUTICALS U.S.A., INC.] | 12 | Current NDC, Legacy NDC, 2 package rows | 20240509_7cb92cf2-46f2-4379-937c-168d230e43a4.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-4045-1 | EA - Each | 51672-4045 | 65069710-3c5b-4339-ba87-09ceb26cf720 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sodium Bicarbonate Antacid | SODIUM BICARBONATE | Menper Distributors Inc. | 6efb4da0-03ae-4df6-acd7-e8023d20d4b3 | 2025-07-22 | Warnings | 8MDF5V39QO |
| Losartan potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Macleods Pharmaceuticals Limited | a04b5622-2c49-4d61-92b1-5dc523af7a24 | 2025-07-21 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Aller-Chord F | ACETALDEHYDE, ACETICUM AC, ARG NIT, CAFFEINUM, CALC SULPH, CITRICUM AC, CORTISONE ACETICUM, ECHINACEA PURP, FOLLICULINUM, FRAGARIA, FUMARICUM AC, GALLICUM AC, GLANDULA SUPRARENALIS SUIS, HEPAR SUIS, HISTAMINUM HYDROCHLORICUM, HYDRANGEA, LAC VAC, LECITHIN, LIMULUS, LYCOPERSICUM, LYCOPODIUM, NAT BICARB, NAT MUR, NUX VOM, PARAFFINUM, PHOSPHORICUM AC, SACCHARUM OFF, SILICEA, TARTARICUM AC, TORULA CEREVISIAE. | Energetix Corporation | ff4eb7b2-8272-4bd3-99a9-7e589b30d59a | 2025-07-15 | Warnings | 8MDF5V39QO |
| Zegerid OTC | OMEPRAOLE, SODIUM BICARBONATE | Riley Consumer Care LLC | 8d00c19a-d86b-4a2f-8791-b320ad3ca781 | 2025-07-15 | Warnings | 8MDF5V39QO |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 73bc116a-2964-4acc-9ef0-0a3f66268913 | 2025-07-14 | Warnings, Adverse reactions | 0J48LPH2TH |
| Olmesartan Medoxomil and Hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 0360db3a-17cf-4d24-97ba-e0a6fcc94351 | 2025-07-14 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Sterile Water | STERILE WATER | Nephron Pharmaceuticals Corporation | bc04a883-babc-87a6-e053-2995a90a3dfd | 2025-07-11 | Warnings, Adverse reactions | 059QF0KO0R |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | f4f026f9-5f21-435e-8878-01dc9bbe2d66 | 2025-07-10 | Warnings, Adverse reactions | 0J48LPH2TH |
| Leader Sinus Wash Saline Refill Packets | SODIUM BICARBONATE, SODIUM CHLORIDE | Cardinal Health, 110 dba LEADER | fb192a6d-318e-4d2b-89b6-42ac023e4fbd | 2025-07-09 | Warnings | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | Westminster Pharmaceuticals, LLC | 9dcfc778-5fd6-4c68-8d37-a5385e374617 | 2025-07-08 | Warnings | 8MDF5V39QO |
| losartan potassium and hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Unichem Pharmaceuticals (USA), Inc. | f61b4ffe-cca6-482d-88fa-adf22cb3fff2 | 2025-07-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| TELMISARTAN AND HYDROCHLOROTHIAZIDE | TELMISARTAN AND HYDROCHLOROTHIAZIDE | Solco Healthcare LLC | 47c8eee0-f0b7-4bd8-97e9-0029aa1b37db | 2025-06-30 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND AMLODIPINE BESYLATE AND HYDROCHLOROTHIAZIDE | Slate Run Pharmaceuticals, LLC | a469adff-25a6-4983-b471-60924d920a86 | 2025-06-30 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Ferrum rosatum Graphites | FERRUM ROSATUM GRAPHITES | Uriel Pharmacy Inc. | 1a4ca338-eada-4c0f-8bce-480244940c89 | 2025-06-27 | Warnings | 1K09F3G675 |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | 8d5a9196-5f1d-2d83-e053-2a95a90a6036 | 2025-06-27 | Warnings, Adverse reactions | 0J48LPH2TH |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Anthea Pharma Private Limited | 0df8cf62-4b49-4ec4-aae4-c4a3e6d76549 | 2025-06-26 | Warnings, Adverse reactions | 8MDF5V39QO |
| Spironolactone and Hydrochlorothiazide | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | d5387b26-90a3-44f0-850b-8aa1219fd26b | 2025-06-26 | Warnings, Adverse reactions | 0J48LPH2TH |
| losartan potassium and hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | eb423f4b-8104-4406-bfc2-8943e517329f | 2025-06-26 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Olmesartan Medoxomil and Hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Inc. | ca1a0aac-d81d-4c0a-91ea-cb719af772bf | 2025-06-25 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 5c4c5907-36f0-461e-b0c9-d51edff32a97 | 2025-06-19 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.